Dr Reddy’s Labs Q3 Results: Profit grows 2% YoY to ₹1413 crore; revenue up 16% – Mint

1. Dr Reddy’s Labs Q3 Results: Profit grows 2% YoY to ₹1413 crore; revenue up 16%  Mint
2. Dr Reddy’s Labs Q3 Preview: Lower Revlimid contribution, subdued US sales to dent earnings growth  Moneycontrol
3. Dr Reddy’s Labs Q3 results: PAT rises 2.5% at Rs 1,413 cr, revenue up 16%  Business Standard
4. Dr Reddy’s Q3 profit up 2% at Rs 1,413 crore; revenue at Rs 8,359 crore  The Times of India
5. Q3FY25: Dr. Reddy’s to focus on continued CapEx investment, R&D and increasing capacity of existing portfolio  The Financial Express

 Dr Reddy’s Labs Q3 Results: Profit grows 2% YoY to ₹1413 crore; revenue up 16%  MintDr Reddy’s Labs Q3 Preview: Lower Revlimid contribution, subdued US sales to dent earnings growth  MoneycontrolDr Reddy’s Labs Q3 results: PAT rises 2.5% at Rs 1,413 cr, revenue up 16%  Business StandardDr Reddy’s Q3 profit up 2% at Rs 1,413 crore; revenue at Rs 8,359 crore  The Times of IndiaQ3FY25: Dr. Reddy’s to focus on continued CapEx investment, R&D and increasing capacity of existing portfolio  The Financial Express  Top stories – Google News